These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 38324940)

  • 1. A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice.
    Valleriani F; Di Pancrazio C; Spedicato M; Di Teodoro G; Malatesta D; Petrova T; Profeta F; Colaianni ML; Berjaoui S; Puglia I; Caporale M; Rossi E; Marcacci M; Luciani M; Sacchini F; Portanti O; Bencivenga F; Decaro N; Bonfante F; Lorusso A
    Virology; 2024 Apr; 592():109997. PubMed ID: 38324940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.
    Liu X; Mostafavi H; Ng WH; Freitas JR; King NJC; Zaid A; Taylor A; Mahalingam S
    mBio; 2022 Jun; 13(3):e0068322. PubMed ID: 35420469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
    Johnson BA; Xie X; Bailey AL; Kalveram B; Lokugamage KG; Muruato A; Zou J; Zhang X; Juelich T; Smith JK; Zhang L; Bopp N; Schindewolf C; Vu M; Vanderheiden A; Winkler ES; Swetnam D; Plante JA; Aguilar P; Plante KS; Popov V; Lee B; Weaver SC; Suthar MS; Routh AL; Ren P; Ku Z; An Z; Debbink K; Diamond MS; Shi PY; Freiberg AN; Menachery VD
    Nature; 2021 Mar; 591(7849):293-299. PubMed ID: 33494095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
    Colunga Biancatelli RML; Solopov PA; Sharlow ER; Lazo JS; Marik PE; Catravas JD
    Am J Physiol Lung Cell Mol Physiol; 2021 Aug; 321(2):L477-L484. PubMed ID: 34156871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice.
    Wong TY; Horspool AM; Russ BP; Ye C; Lee KS; Winters MT; Bevere JR; Miller OA; Rader NA; Cooper M; Kieffer T; Sourimant J; Greninger AL; Plemper RK; Denvir J; Cyphert HA; Barbier M; Torrelles JB; Martinez I; Martinez-Sobrido L; Damron FH
    J Virol; 2022 Mar; 96(6):e0218421. PubMed ID: 35080423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.
    Thieulent CJ; Dittmar W; Balasuriya UBR; Crossland NA; Wen X; Richt JA; Carossino M
    mSphere; 2023 Feb; 8(1):e0055822. PubMed ID: 36728430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models.
    Dhanushkodi NR; Prakash S; Quadiri A; Zayou L; Srivastava R; Shaik AM; Suzer B; Ibraim IC; Landucci G; Tifrea DF; Singer M; Jamal L; Edwards RA; Vahed H; Brown L; BenMohamed L
    J Immunol; 2024 Feb; 212(4):576-585. PubMed ID: 38180084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic mice.
    Choi S; Lee J; Kim S; Lee YW; Kim GC; Hong SM; An SH; Noh H; Kim KE; On D; Lee SG; Jang HJ; Kim SH; Kim J; Seo JS; Kim JJ; Park IH; Oh J; Kim DJ; Yoon JH; Seok SH; Lee YJ; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Park JW; Yun JW; Shin JS; Seo JY; Nam KT; Choi KS; Kwon HK; Lee HY; Kim JK; Seong JK
    EBioMedicine; 2024 Jan; 99():104932. PubMed ID: 38118400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.
    Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice.
    da Silva Santos Y; Gamon THM; de Azevedo MSP; Telezynski BL; de Souza EE; de Oliveira DBL; Dombrowski JG; Rosa-Fernandes L; Palmisano G; de Moura Carvalho LJ; Luvizotto MCR; Wrenger C; Covas DT; Curi R; Marinho CRF; Durigon EL; Epiphanio S
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains.
    Radvak P; Kwon HJ; Kosikova M; Ortega-Rodriguez U; Xiang R; Phue JN; Shen RF; Rozzelle J; Kapoor N; Rabara T; Fairman J; Xie H
    Nat Commun; 2021 Nov; 12(1):6559. PubMed ID: 34772941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Pathogenicity of SARS-CoV-2 Delta and Omicron Variants by Analyzing the Expression Patterns of Immune Response Genes in K18-hACE2 Transgenic Mice.
    Kuruppuarachchi KAPP; Jang Y; Seo SH
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):316. PubMed ID: 36472114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.
    Ávila-Nieto C; Vergara-Alert J; Amengual-Rigo P; Ainsua-Enrich E; Brustolin M; Rodríguez de la Concepción ML; Pedreño-Lopez N; Rodon J; Urrea V; Pradenas E; Marfil S; Ballana E; Riveira-Muñoz E; Pérez M; Roca N; Tarrés-Freixas F; Cantero G; Pons-Grífols A; Rovirosa C; Aguilar-Gurrieri C; Ortiz R; Barajas A; Trinité B; Lepore R; Muñoz-Basagoiti J; Perez-Zsolt D; Izquierdo-Useros N; Valencia A; Blanco J; Guallar V; Clotet B; Segalés J; Carrillo J
    Nat Commun; 2024 Mar; 15(1):2349. PubMed ID: 38514609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice.
    Gutman H; Aftalion M; Melamed S; Politi B; Nevo R; Havusha-Laufer S; Achdout H; Gur D; Israely T; Dachir S; Mamroud E; Sagi I; Vagima Y
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host immune responses associated with SARS-CoV-2 Omicron infection result in protection or pathology during reinfection depending on mouse genetic background.
    Singh G; Warang P; García-Bernalt Diego J; Chang L; Bykov Y; Singh S; Pache L; Cuadrado-Castano S; Webb B; Garcia-Sastre A; Schotsaert M
    Res Sq; 2023 Nov; ():. PubMed ID: 38077015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype.
    Barut GT; Halwe NJ; Taddeo A; Kelly JN; Schön J; Ebert N; Ulrich L; Devisme C; Steiner S; Trüeb BS; Hoffmann B; Veiga IB; Leborgne NGF; Moreira EA; Breithaupt A; Wylezich C; Höper D; Wernike K; Godel A; Thomann L; Flück V; Stalder H; Brügger M; Esteves BIO; Zumkehr B; Beilleau G; Kratzel A; Schmied K; Ochsenbein S; Lang RM; Wider M; Machahua C; Dorn P; Marti TM; Funke-Chambour M; Rauch A; Widera M; Ciesek S; Dijkman R; Hoffmann D; Alves MP; Benarafa C; Beer M; Thiel V
    Nat Commun; 2022 Oct; 13(1):5929. PubMed ID: 36207334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.
    Ogger PP; Martín MG; Jang S; Zhou J; Brown J; Sukhova K; Furnon W; Patel AH; Cowton V; Palmarini M; Barclay WS; Johansson C
    Front Immunol; 2024; 15():1383612. PubMed ID: 38742107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.